Clinical trials recruiting in Pforzheim, Germany
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 1Not applicable 8
Conditions recruiting in Pforzheim, Germany
Recruiting trials in Pforzheim, Germany
- A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
- Clinical Outcomes Study of the Nexel Total Elbow
- PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
- Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
- Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Zimmer Biomet Shoulder Arthroplasty PMCF Study
Common questions
How many clinical trials are recruiting in Pforzheim, Germany?
9 recruiting trials have at least one study site in Pforzheim, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.